Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor

Paul J. Davis, Faith B. Davis, Hung Yun Lin, Shaker A. Mousa, Min Zhou, Mary K. Luidens

研究成果: 雜誌貢獻文章

57 引文 (Scopus)

摘要

A thyroid hormone receptor on integrin αvβ3 that mediates cell surface-initiated nongenomic actions of thyroid hormone on tumor cell proliferation and on angiogenesis has been described. Transduction of the hormone signal into these recently recognized proliferative effects is by extracellular-regulated kinases 1/2 (ERK1/2). Other nongenomic actions of the hormone may be transduced by phosphatidylinositol 3-kinase (PI3K) and are initiated in cytoplasm or at the cell surface. PI3K-mediated effects are important to angiogenesis or other recently appreciated cell functions but apparently not to tumor cell division. For those actions of thyroid hormone [L-thyroxine (T4) and 3,3′-5-triiodo-L-thyronine (T 3)] that begin at the integrin receptor, tetraiodothyroacetic acid (tetrac) is an inhibitor of and probe for the participation of the receptor in downstream intracellular events. In addition, tetrac has actions initiated at the integrin receptor that are unrelated to inhibition of the effects of T 4 and T3 but do involve gene transcription in tumor cells. Discussed here are the implications of translating these nongenomic mechanisms of thyroid hormone analogs into clinical cancer cell biology, tumor-related angiogenesis, and modulation of angiogenesis that is not related to cancer.
原文英語
期刊American Journal of Physiology - Endocrinology and Metabolism
297
發行號6
DOIs
出版狀態已發佈 - 十二月 2009
對外發佈Yes

指紋

Thyroid Hormones
Integrins
Phosphatidylinositol 3-Kinase
Neoplasms
Thyronines
Hormones
Thyroid Hormone Receptors
Thyroxine
Cell Division
Cell Biology
Signal Transduction
Cytoplasm
Phosphotransferases
Cell Proliferation
Genes

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Endocrinology, Diabetes and Metabolism

引用此文

Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor. / Davis, Paul J.; Davis, Faith B.; Lin, Hung Yun; Mousa, Shaker A.; Zhou, Min; Luidens, Mary K.

於: American Journal of Physiology - Endocrinology and Metabolism, 卷 297, 編號 6, 12.2009.

研究成果: 雜誌貢獻文章

@article{7b8d6f9388404feda86ac8e60847ea15,
title = "Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor",
abstract = "A thyroid hormone receptor on integrin αvβ3 that mediates cell surface-initiated nongenomic actions of thyroid hormone on tumor cell proliferation and on angiogenesis has been described. Transduction of the hormone signal into these recently recognized proliferative effects is by extracellular-regulated kinases 1/2 (ERK1/2). Other nongenomic actions of the hormone may be transduced by phosphatidylinositol 3-kinase (PI3K) and are initiated in cytoplasm or at the cell surface. PI3K-mediated effects are important to angiogenesis or other recently appreciated cell functions but apparently not to tumor cell division. For those actions of thyroid hormone [L-thyroxine (T4) and 3,3′-5-triiodo-L-thyronine (T 3)] that begin at the integrin receptor, tetraiodothyroacetic acid (tetrac) is an inhibitor of and probe for the participation of the receptor in downstream intracellular events. In addition, tetrac has actions initiated at the integrin receptor that are unrelated to inhibition of the effects of T 4 and T3 but do involve gene transcription in tumor cells. Discussed here are the implications of translating these nongenomic mechanisms of thyroid hormone analogs into clinical cancer cell biology, tumor-related angiogenesis, and modulation of angiogenesis that is not related to cancer.",
author = "Davis, {Paul J.} and Davis, {Faith B.} and Lin, {Hung Yun} and Mousa, {Shaker A.} and Min Zhou and Luidens, {Mary K.}",
year = "2009",
month = "12",
doi = "10.1152/ajpendo.00480.2009",
language = "English",
volume = "297",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor

AU - Davis, Paul J.

AU - Davis, Faith B.

AU - Lin, Hung Yun

AU - Mousa, Shaker A.

AU - Zhou, Min

AU - Luidens, Mary K.

PY - 2009/12

Y1 - 2009/12

N2 - A thyroid hormone receptor on integrin αvβ3 that mediates cell surface-initiated nongenomic actions of thyroid hormone on tumor cell proliferation and on angiogenesis has been described. Transduction of the hormone signal into these recently recognized proliferative effects is by extracellular-regulated kinases 1/2 (ERK1/2). Other nongenomic actions of the hormone may be transduced by phosphatidylinositol 3-kinase (PI3K) and are initiated in cytoplasm or at the cell surface. PI3K-mediated effects are important to angiogenesis or other recently appreciated cell functions but apparently not to tumor cell division. For those actions of thyroid hormone [L-thyroxine (T4) and 3,3′-5-triiodo-L-thyronine (T 3)] that begin at the integrin receptor, tetraiodothyroacetic acid (tetrac) is an inhibitor of and probe for the participation of the receptor in downstream intracellular events. In addition, tetrac has actions initiated at the integrin receptor that are unrelated to inhibition of the effects of T 4 and T3 but do involve gene transcription in tumor cells. Discussed here are the implications of translating these nongenomic mechanisms of thyroid hormone analogs into clinical cancer cell biology, tumor-related angiogenesis, and modulation of angiogenesis that is not related to cancer.

AB - A thyroid hormone receptor on integrin αvβ3 that mediates cell surface-initiated nongenomic actions of thyroid hormone on tumor cell proliferation and on angiogenesis has been described. Transduction of the hormone signal into these recently recognized proliferative effects is by extracellular-regulated kinases 1/2 (ERK1/2). Other nongenomic actions of the hormone may be transduced by phosphatidylinositol 3-kinase (PI3K) and are initiated in cytoplasm or at the cell surface. PI3K-mediated effects are important to angiogenesis or other recently appreciated cell functions but apparently not to tumor cell division. For those actions of thyroid hormone [L-thyroxine (T4) and 3,3′-5-triiodo-L-thyronine (T 3)] that begin at the integrin receptor, tetraiodothyroacetic acid (tetrac) is an inhibitor of and probe for the participation of the receptor in downstream intracellular events. In addition, tetrac has actions initiated at the integrin receptor that are unrelated to inhibition of the effects of T 4 and T3 but do involve gene transcription in tumor cells. Discussed here are the implications of translating these nongenomic mechanisms of thyroid hormone analogs into clinical cancer cell biology, tumor-related angiogenesis, and modulation of angiogenesis that is not related to cancer.

UR - http://www.scopus.com/inward/record.url?scp=72249119235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72249119235&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00480.2009

DO - 10.1152/ajpendo.00480.2009

M3 - Article

C2 - 19755667

AN - SCOPUS:72249119235

VL - 297

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 6

ER -